Insulet (PODD) Gross Profit (2009 - 2025)

Insulet has reported Gross Profit for 17 years, with the latest figure at $1.9 billion in FY2025.

• For the quarter ending Q1 2026, Gross Profit rose 29.36% year-over-year to $529.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 33.08% YoY), and the FY2025 full-year result was $1.9 billion, up 34.18% from the prior year.
• Gross Profit for FY2025 stood at $1.9 billion, up from $1.4 billion in the prior year.
• The five-year high for Gross Profit was $1.9 billion in FY2025, with the low at $752.1 million in FY2021.
• Historically, Gross Profit has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
• Annual changes were most pronounced in 2022 — Gross Profit climbed 7.11% — and 2023, when it soared 43.98%.
• Insulet's Gross Profit stood at $752.1 million in 2021, then increased by 7.11% to $805.6 million in 2022, then surged by 43.98% to $1.2 billion in 2023, then rose by 24.64% to $1.4 billion in 2024, then jumped by 34.18% to $1.9 billion in 2025.
• The last three Gross Profit figures came in at $1.9 billion (FY2025), $1.4 billion (FY2024), and $1.2 billion (FY2023), per Business Quant data.